STAT1 as a tool for non-invasive monitoring of NK cell activation in cancer

Area of Science:

• Immunology
• Cancer Biology
• Biotechnology

Background:

• Natural killer (NK) cells are vital for cancer immunotherapy, possessing inherent tumor-targeting capabilities.
• Current in vivo visualization methods for NK cell activity against tumors are limited, hindering treatment monitoring.
• Understanding NK cell activation is crucial for optimizing cancer therapies.

Purpose of the Study:

• To develop a non-invasive imaging method for tracking NK cell activation in real-time.
• To visualize the interaction between NK cells and cancer cells using STAT1 protein as a biomarker.
• To enhance the monitoring and prediction of NK cell-based cancer immunotherapies.

Main Methods:

• Engineered natural killer (NK) cells (GAS-NK) were created with a specific genetic sequence that binds to STAT1 upon activation.
• The functionality of GAS-NK cells was validated through various biological assays.
• The imaging method was tested in cancer environments and patient-derived cancer organoid models.

Main Results:

• The engineered GAS-NK cells successfully demonstrated their ability to track NK cell activation.
• The method allowed for non-invasive visualization of NK cell activity in response to cancer cells.
• Observations confirmed the effectiveness of the approach in relevant cancer models.

Conclusions:

• The developed imaging method provides a novel way to monitor NK cell activity in cancer immunotherapy.
• This technique can potentially improve the prediction and efficacy assessment of NK cell-based cancer treatments.
• The findings contribute to advancing the field of cancer immunotherapy by enabling better visualization of immune responses.